Updated on 16 September 2026
Freedom to Operate for Pharma & Biotech: Confidential Conversation in English or Spanish
Patent Adviser at ZBM Patents
Madrid, Spain
About
Are you developing or commercialising a pharmaceutical or biotech product and want to understand whether third-party patent rights could affect your freedom to operate?
We'd be happy to have a confidential, no-obligation conversation in either English or Spanish on freedom-to-operate issues in the life sciences. You can bring a specific product, technology or concern, or simply use the meeting to discuss when an FTO analysis may be useful and how it can inform your development and commercial strategy.
FTO considerations can be particularly important when approaching clinical development, partnering, licensing, investment or market entry. We would be happy to discuss your situation and help identify the IP questions that may warrant closer analysis.
Field
- Biotech, Pharma and Cosmetics
- Food, Beverages and Agriculture
- Healthcare
- Nano- and Microtechnologies
Organisation
Similar opportunities
Expertise
Patents & IP Strategy for Pharma & Biotech: Confidential Conversation in English or Spanish
- Healthcare
- Nano- and Microtechnologies
- Biotech, Pharma and Cosmetics
- Food, Beverages and Agriculture
Irina Stefana
Patent Adviser at ZBM Patents
Madrid, Spain
Expertise
Patent and IP Strategy for Pharma Innovation
- Healthcare
- Biotech, Pharma and Cosmetics
Tomás Llamas
European Patent Attorney & Partner at ABG INTELLECTUAL PROPERTY
Madrid, Spain
Service
Patent and IP Protection for Pharmaceutical Innovations
- Consulting
- Cosmetic industry
- Health innovation
- Pharmaceutical industry
Tomás Llamas
European Patent Attorney & Partner at ABG INTELLECTUAL PROPERTY
Madrid, Spain